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Recurrent airway inﬂammations in children are an important clinical problem in pediatric practice. An essential challenge is
diﬀerentiation between allergic background and immune deﬁciency, which is a diﬃcult task taking into consideration individual
predisposition to atopy, immune system maturation in the early childhood, as well as exposition to environmental allergens
and microbial antigens. In this paper relationship between selected elements of innate and adaptive immunity, such as pattern-
recognition receptors, complement components, dendritic cells, as well as immunoglobulins, and regulatory T lymph cells has
been discussed. Particular attention has been paid to these mechanisms of the immune response which, depending on settings and
timing of activation, predispose to allergy or contribute to tolerogenic phenotype. In the context of multifactorial conditioning
of the innate and adaptive immunity governing the ultimate response and associations between allergy and immune deﬁciencies,
these phenomena should be considered as pathogenetically not precluding, but as an overlapping syndrome.
1.Introduction
Development of the immune response in childhood is
a dynamic process initiated within the fetal period and
expanding in time through months and even years of child’s
life. Physiological phenomenon of immune system matura-
tion, type and timing of activating allergens, and microbial
antigensinconjunctionwithgeneticpredispositiontoallergy
are of crucial importance in determination of the proallergic
or tolerogenic phenotype. Clinically, these considerations
apply particularly to diagnostic and therapeutic dilemmas
regarding recurrent airway inﬂammations in children, in
which major questions concern diﬀerentiation between
allergy and immune deﬁciency. Establishing a diagnosis
is an essential challenge including common clinical man-
ifestations, reciprocal impact of diﬀerent clinical entities,
overlapping pathomechanisms of allergic background, and
defects of innate and adaptive immune responses, as well
as deﬁciencies in factors playing a hitherto unexpected
immunoregulatory role.
2. Maturation of the Immune System
Physiological phenomenon of maturation of the immune
system, initiated within the fetal period, is dynamic in
its character and is expanding in time through the ﬁrst
months and even years of child’s life. Hence, within the
neonatal period, infancy and early childhood dysfunction of
numerous components of the immune system is observed.
Within the neonatal period, considerable immaturity
characterizes the system of monocytes-macrophages. It
consists in decreased expression of costimulatory molecules
and diminished ability to diﬀerentiation into dendritic
c e l l sa sw e l la sw e a kp r o d u c t i o no fI L - 1 2b ym o n o c y t e s
[1]. Macrophages exhibit diminished response to IFNγ,
decreased activity upon phagocytosis [1], and impairment of
intracellular killing [2].
In neonates, the immaturity concerns function of den-
dritic cells. This consists in downregulated expression of cos-
timulatory molecules by myeloid (mDC) and of plasmacy-
toid(pDC)dendriticcells,defectivematurationandsynthesis2 Journal of Allergy
of cytokines—IFNγ and IL-12 as the response to signaling
pathways downstream of Toll-like receptors engagement,
particularly TLR4 and TLR9 and CD40 molecule as well
as impaired ability to stimulate the immune response by
pDC. The proposed mechanisms to explain the dysfunction
of neonatal DC comprise intrinsic immaturity, defective
interactionbetweendendriticcellsandTlymphocytesaswell
as modulatory eﬀect of natural regulatory T cells (nTreg).
These cells, playing an important role during pregnancy
and maintaining maternal tolerance to the fetus, are present
in high numbers in neonates and are critical in maintain-
ing homeostasis, immunological tolerance, and preventing
autoimmunity. Neonatal nTregs exert their immunosup-
pressive function by the mechanism of interaction between
molecules CTLA-4 and CD80/CD86 on antigen-presenting
cells and by secretion of L-10 and TGFβ [1].
Functional alterations of neonatal antigen-presenting
cells may in turn lead to secondary defects of adaptive T-cell
response. In neonates occurs a T-cell functional deﬁciency
manifesting as downregulated expression of TCR/CD3 com-
plex,adhesionmoleculesandCD40ligand(CD40L,CD154),
impaired cytotoxic activity of CD8+ T cells as well as
decreased cytokine synthesis. Expression of a range of
cytokines playing an essential role in the immune response,
such as IL-4, IL-5, IFNγ,T N F α, and IL-12, is a dynamic
process and their production increases with child’s age [3].
Hodge et al. demonstrated a diminished number of neonatal
T lymph cells and NK cells exhibiting expression of β
chain of the IL-2 receptor. Moreover, the production level
of cytokines such as IL-1α,I L - 1 β,a n dT N F α was lower
compared to adults, pointing to decreased capacity to mount
eﬀective inﬂammatory response. On the contrary, the level
and kinetics of expression of other functional molecules—
CD71, HLA-DR; and CD152—were comparable to that in
adults [4].
Predominance of the Th2-dependent immune response
prevailing within the fetal period and expanding through
the neonatal period and infancy [5–7]m a yb ea m o n g
others as a result of exerted activity of regulatory T cells,
suppressing the proinﬂammatory Th1-mediated response
[8]. Moreover, mechanisms of the innate immune response
proﬁling development of the adaptive response towards
advantageous Th1-or Th2-mediated immunity contribute to
the predisposition or to the protection from asthma and
allergy.Dose, settings, and timing of exposure to antigens are
of crucial importance in modulating the immune response
proﬁle within the child’s early life [9, 10].
Immaturity of the eﬀector mechanisms and suppressive
activity of the transplacentally transmitted maternal IgG
antibodiescontributetotheconsequentdeﬁciencyofspeciﬁc
humoral response [5]. In neonates, rapid increase of the
immunoglobulin M active in primary immune response to
antigens, relatively high concentration of IgG of maternal
originandweakproductionofchild’sownimmunoglobulins
IgG and IgA manifest as dysgammaglobulinemia and reﬂect
distinct dynamics of diﬀerent isotype synthesis. In infants
between the second and sixth months of life hypogamma-
globulinemia continues as a result of still weak production
of own and the breakdown of maternal immunoglobulin
G. Delayed maturation of the humoral response manifests
frequently as transient hypogammaglobulinemia of infancy
(THI), which abates typically until the end of the second
year of life [11], but may be prolonged even up to the
ﬁfth or sixth year of life [12] and hitherto the evaluation,
if the immune defect in a child is transient or is signaling
a permanent primary immune deﬁciency, may be diﬃcult.
In the recent study of Keles et al. [13], evaluating clinical
and immunological features of THI children, asthma was the
leading health problem present in 52% of patients.
3.AllergicDiseasesCoexistingwith
Immune Deﬁciencies
3.1. Antibody Production Defects. To the clinical problem
of concomitant occurrence of allergic diseases and primary
immune deﬁciencies in children drew attention Klemola,
whoreportedsymptomsofatopicdiseasesin50%ofchildren
with selective IgA deﬁciency (sIgAD) [14]. Interestingly, it
was noted a better correlation between the prevalence and
severity of the clinical course of allergic diseases in children
within the ﬁrst two years of life and a low normal IgA
concentrationinserumthanaconcentrationofIgEincreased
above the normal value for age [15]. In the prospective study
evaluating the same group of children at the age of four
years, it was observed an association between occurrence
of allergic diseases and asthma and decreased IgA and
IgG4 subclass in serum as well as secretory salivary IgA
[16]. The Papadopoulou study revealed not solely a higher
prevalence of atopy in a group of children with selective IgA
deﬁciency compared to a control group, but also pointed
to the more frequent coexisting bronchial hyperreactivity
and hypersensitivity to Dermatophagoides pteronyssinus in
children with sIgAD [17]. The results of the study performed
by Kutukculer et al. [18] indicated that partial IgA deﬁciency
and IgG subclass deﬁciency are transient in 52% and
51% children, respectively, and that increases in serum
immunoglobulins to age-related normal levels occur up to
the sixth year of life. Exactly, in this group of children
atopic diseases proved to occur more frequently than among
children with complete selective IgA deﬁciency (in 41% and
24% patients, resp.). An analysis of correlation between
clinical and immunological phenotypes was done in the
recentreportofIranianauthors[19]onthegr oupofpatients
aged 4–32 years, showing IgA concentration below 62mg/dl.
Recurrentairwayinﬂammationswerethemostfrequentclin-
ical problems, referring to 94% of patients. Allergic diseases-
asthma,atopicdermatitis,allergicrhinitis,andconjunctivitis
were diagnosed in 84% of patients, indicating the fact that
not only a predisposition to infections resulting from an
immunodeﬁciency solely, but also an allergic background
considerably aﬀects the clinical manifestation of the disease.
Interestingly,anasthmaticphenotypewaspresentexclusively
in patients with selective IgA deﬁciency amounting 62% of
the study group. On the contrary, in 38% of patients, who
suﬀered from a complex immunodeﬁciency consisting in
IgA deﬁciency, IgG subclass deﬁciency, deﬁciency of speciﬁc
antibodies against polysaccharide antigens (sAbDs), andJournal of Allergy 3
infections of the respiratory tract predominated as clinical
manifestations and exclusively in this group of patients
occurrenceofbronchiectaseswasobserved.Moraesetal.[20]
in the study on the group of 41 severe asthmatic children
showed an association between the degree of asthma control
and recurrent airway infections as well as deﬁciencies within
the immune system. In children with poor asthma control
more frequently than in children with suﬃciently controlled
asthma (66% versus 55% of children) a deﬁciency of one
or more IgG subclasses and IgG3 or IgG4 deﬁciency were
diagnosed as well as solely in this group of children, a
combined IgA and IgG subclass deﬁciency was revealed.
Single reports in the literature concerning selective
immunoglobulin M deﬁciency (sIgMD) in pediatric pop-
ulation and in adults point to the recurrent respiratory
tract infections as the predominant clinical feature. Allergic
diseases and asthma coexist with this immune deﬁciency in
7-8% of aﬀected children [21] and as much as 33% of adult
patients [22].
Interestingly,anassociationbetweenallergicdiseasesand
immune deﬁciencies was observed in patients manifesting
profound defects of antibody production. Shabestari et al.
[23] reported a case of a boy with Bruton’s agamma-
globulinemia in whom concentrations of main classes of
immunoglobulins were decreased within all isotypes includ-
ing IgE (<0,1IU/ml), B lymph cells bearing antigens CD19
and CD20 amounted less than 1% of normal value for
age and the disease was conﬁrmed by BTK gene mutation.
Recurrentepisodesofrespiratoryinfectionswithobstruction
of the lower airways were the most important clinical symp-
toms, and in additional diagnostic examinations, positive
skin prick tests with alimentary and airborne allergens as
well as bronchial hyperreactivity in spirometry were noted.
A bias towards Th2-mediated immune response was also
documented in patients with common variable immunod-
eﬁciency (CVID) through investigation of cytokine levels
and demonstration of increased IL-4 and IL-10 production
[24]. A high incidence of asthma, usually diagnosed after the
initial presentation, was seen in 83% of pediatric patients
with CVID as it was reported by Ogershok et al. [25].
3.2. Complement Deﬁciencies. Associations between aller-
gic background of respiratory symptoms and immune
defects are not exclusively conﬁned to a dysregulation of
immunoglobulin production and impaired balance between
Th1 and Th2 lymph cells compartments. These phenomena
are also determined by the activity of complement pathway
components, establishing links between innate and adaptive
immune responses. Although each pathway is activated
by distinct pathway recognition receptors (PRRs), they all
culminate in activation of C3 component, a central step
in complement activation. Activation of C3 leads to the
generation of anaphylatoxins C3a and C5a, which through
binding their receptors on inﬂammatory cells proved to
induce pathophysiological features of allergic inﬂammation.
In support of this proallergic role of C3, its deﬁciency
was shown on an animal model to have a protective
eﬀect against antigen-induced bronchial hyperreactivity [26,
27]. C5a, in turn, in allergic inﬂammation plays a dual
role, both promoting and protective, depending on the
inﬂammatory cells and cytokine environment upon its
activation. Immunological role of C5a component consists
principally in modulation of the adaptive immune response
through altering the phenotype and function of antigen-
presenting dendritic cells [28]. A deﬁciency in C5a leads
to a shift of the proportion of the myeloid dendritic cells
(mDCs) to plasmacytoid dendritic cells (pDCs), and to the
consequent development of Th2-dependent eﬀector phase.
In this condition of a lack of C5a also an increase of the
production of Th2-speciﬁc chemokines, CCL17 and CCL22
by pulmonary mDCs occurs, enhancing homing of Th2
lymph cells [29]. Impairment of the immune tolerance
results from a defective stimulation of pDCs and absence
of regulatory T-cell induction, corroborating a concept
of a tolerogenic role of C5a and protective eﬀect during
allergen sensitization. A recognition of pattern-associated
molecular patterns (PAMPs) leads to the activation of
complement pathway by lectin proteins. A decreased level
of a mannose-binding lectin (MBL), playing an important
role in opsonization, was found in a group of asthmatic
children [30]. Moreover, an association was shown between
an allelic variant of MBL2 gene leading to decreased MBL
concentrationinserumandhigherriskofasthmainchildren
presentingwithrecurrentandchronicChlamydiapneumonia
infection [31]. In adults an allelic MBL variant was not
only associated with predisposing eﬀect to asthma, but also
correlated with a decrease in lung function [32].
Ficolins M, L, and H (1, 2, and 3, resp.), structurally
similar to collectins, MBL, and surfactant protein A and D
initiate the lectin pathway of complement activation through
serin proteases MASPs [33]. Cedzynski et al. reported an
association between relative L-ﬁcolin deﬁciency and recur-
rentrespiratoryinfectionscoexistingwithasthmainchildren
[34].
Deﬁciencies of humoral innate and adaptive immune
responses associated with proallergic eﬀect are displayed on
Figure 1.
3.3. Phagocyte Defect. Fitzpatrick et al. [35] demonstrated
impaired alveolar macrophage phagocytosis in children with
poorly controlled asthma. These ﬁndings suggest that a
functional deﬁciency of innate immunity contributes to
a defective antimicrobial response and recurrent airway
inﬂammationresultinginexacerbationsofasthma.Thisphe-
nomenon of impaired phagocytosis may be explained by an
alternative mechanism of macrophage activation potentiated
by IL-4 in the Th2 microenvironment, where inhibition of
phagocytosisassociatedwithdefectivephagosomeformation
and concomitant increased proinﬂammatory cytokine secre-
tion was observed by Varin et al. [36].
4. Role of Regulatory T Lymphocytes
Natural Treg cells of a CD4+CD25+ phenotype are best
characterized by an intracellular marker, a transcription
factor Foxp3, playing an essential role in development and4 Journal of Allergy
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Figure 1: Humoral defects of innate and adaptive immune responses associated with proallergic eﬀect.
activity of these cells [37–40]. Inducible regulatory T lymph
cells (iTreg, Tr1) arise as a result of activation of mature
T cells in the settings lacking an optimal exposure to
antigen or costimulation as well as in the environment of
inhibitory cytokines and are characterized by IL-10 and
TGFβ production. Na¨ ıve CD4+ T cells may also develop into
Tr1cellsinthepresenceofchronicstimulationwithallergens
infectious and tumor antigens. However, the suppressive
function is not strictly Treg-speciﬁc and all CD4+ T cells
exhibit suppressive activity in diﬀerent degree. Mechanisms
determining types of immune response and their mutual
relationship as a result of transcription factors and cytokine
activities towards CD4+ T cell subsets are displayed on
Figure 2.
For T regulatory lymphocytes, the following nonexclu-
sive functions are proposed: prevention of autoimmunity
by establishing and maintaining immunological tolerance
to self-antigens, induction of maternal tolerance to the
fetus, induction of tolerance against alimentary antigens,
and suppression of pathogen-induced immunopathology
[38, 39].
In allergic diseases and asthma, activation of CD4+ T
cells plays a key role and allergic inﬂammation in the airways
is mediated by subpopulations of eﬀector Th2 and Th17
cells. Regulatory T cells, both nTregs having CD4+CD25+
phenotype and antigen-induced IL-10 secreting Tr1 cells
achieve their regulatory eﬀect by diﬀerent pathways, inhibit-
ing dendritic cells activity, suppressing eﬀector Th2 and
Th17 cells, suppressing mast cells and basophils, as well as
decreasing migration of inﬂammatory cells to target tissues
[41–44]. They also downregulate IgE synthesis and stimulate
class switching towards anti-inﬂammatory isotypes—IgG4
subclass and, in a lesser extent, to IgA. Induction of IgA
synthesis is ﬁrst of all determined by activation of B lympho-
cytes through Toll-like receptors TLR9 and TLR7 pathway
[45] .H a r t le ta l .[ 46] reported signiﬁcantly decreased
number of CD4+CD25+ T cells and lower concentration of
cytokines IL-10 and TGFβ in bronchoalveolar lavage ﬂuid
of asthmatic as compared to healthy children. Likewise, in
patients manifesting symptoms of atopic diseases, Saito [47]
demonstrated a smaller proportion of cells Foxp3+CD4+
than in asymptomatic individuals in the control group,
having similar concentrations of IFNγ and IgE in serum
as well as blood eosinophil count. These above-mentioned
ﬁndings suggest that development of symptoms of allergic
diseases is determined by mutual relationship between
proinﬂammatory Th2 and Th17 lymph cells subsets and
regulatory T cells. Recently, novel distinct populations of
eﬀector T helper cells involved in tissue inﬂammation have
been demonstrated, namely Th9 cells, characterized by IL-9
and IL-10 secretion [48], and Th22 cells with IL-22 secretion
and low expression levels of IL-17 [49, 50].
A deﬁciency of regulatory T cells resulting from FOXP3
gene mutation is an essential factor in pathogenesis of
IPEX syndrome (immune dysregulation, polyendocrinopa-
thy, enteropathy, X-linked) [51]. In a range of primary
immune deﬁciency diseases an immunological dysregulation
may be consequent to functional regulatory T cells impair-
ment and predominating Th2-dependent immune response,
as it was demonstrated in patients with common variable
immunodeﬁciency,adisorderpredisposingtoautoimmunity
[52, 53]. A Th17 cells deﬁciency is a crucial immune abnor-
mality in the hyperimmunoglobulin E syndrome (HIES), a
complex immunodeﬁciency with a constellation of diverse
clinical manifestations, unique predisposition to staphylo-
coccal and mycotic infections, and heterogeneous genetic
origin. In autosomal dominant hyper-IgE syndrome (AD-
HIES) hypomorphic mutations in STAT3 (signal transducer
and activator of transcription) gene has been demonstrated
[54], leading to impaired Th17 cells diﬀerentiation andJournal of Allergy 5
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Figure 2: Mechanisms determining types of immune response and their mutual relationship as a result of transcription factors and cytokine
activities towards CD4+ T cell subsets.
defective multiple cytokine signaling, resulting in impaired
upregulationofantimicrobialpeptides[55].Patientsaﬀected
with autosomal recessive hyper-IgE syndrome (AR-HIES)
due to DOCK8 (dedicator of cytokinesis 8) [56]o rTyk2
(tyrosine kinase 2) gene mutation [57] share common
features of HIES, such as elevated serum IgE concentration
and eosinophilia as well as predisposition to staphylococcal
and candidal infections however, diﬀerent infection proﬁle
and clinical features suggest a distinct disease entity.
Primary immune deﬁciencies of diﬀerent genetic back-
ground associated with T-cell dysfunction and aberrant IgE
production are displayed in Table 1.
5. Immunomodulatory Role of Pattern
RecognitionReceptors(PRRs)
Toll-like receptors (TLRs), along with retinoid acid-induci-
ble gene-I-like receptors (RLRs) and nucleotide-binding
oligomerization domain- (NODs) like receptors (NLR) are
crucial elements of innate arm of immunity, recogniz-
ing pathogen-associated molecular patterns (PAMPs), and
molecular structures speciﬁc for microbial pathogens. They
are expressed in diﬀerent cellular compartments, such as
cell surface, endosome, lysosome or cytoplasm, and activate
speciﬁc signaling pathways leading to expression of genes
that tailor immune responses to particular microbes [58].
Toll-like receptors TLR1, TLR2, TLR4, TLR6, and TLR10
detect extracellular pathogen-associated signatures, while
TLR3, TLR7, TLR8, and TLR9 recognize ligands derived
from intracellular viral and bacterial pathogens.
In B lymph cells, Toll-like receptors activation results in
upregulation of activation markers, proliferation, cytokine
secretion, terminal diﬀerentiation, and immunoglobulin
secretion. It has been demonstrated that TLR9 stimulation
of B cells with CpG motifs induces IgG class switch recom-
bination (CSR). This eﬀect results in inhibition of the IL-4
and CD40-dependent IgG1/IgE class switch and suppression
of IgE production as well as simultaneous stimulation of IgA
synthesis [59].
Extensive interactions and crosstalk among TLRs and
other surface receptors is a characteristic feature of TLRs
[60]. Both microbial antigens and allergens represent impor-
tant trigger factors with eﬀect on antigen-presenting cells
and eﬀector cells involved in allergic reactions. Therefore,
it is likely that not separate but concomitant stimulation
of both receptor types, namely, Toll-like receptors and
high-aﬃn i t yr e c e p t o rf o rI g E( F c εRI) may occur under
physiological conditions and in particular in the context of
allergic and infectious diseases. Potential counterregulation
andinteractionofTLRswithIgEreceptor-mediatedimmune
response along with integrated signal from diﬀerent receptor
networks may therefore compose mechanisms which pro-
mote development of allergy [60].
Diﬀerent TLRs, in particular TLR2 and TLR4 have been
demonstrated to be expressed on mast cells, which can be
activated to secrete diverse mediators and cytokines by IgE
as well as speciﬁc antigens and products derived from either
pathogens or the host during innate and adaptive immune
responses [61, 62]. Depending on the type of ligand, TLR2
displays modulatory eﬀect on FcεRI-mediated signaling6 Journal of Allergy
Table 1: Primary immune Deﬁciencies and their genetic background, associated with T-cell dysfunction and aberrant IgE production.
Primary immune deﬁciencies with elevated IgE
T-cell dysfunction Immune deﬁciency Genetic background
Treg cell deﬁciency
Immune dysregulation,
polyendocrinopathy,
enteropathy, X-linked
(IPEX)
Forkhead box protein 3 (Foxp3) signal
transducer and activator of transcription 5b
(STAT5b)CD25
Treg cell dysfunction Wiskott-Aldrich syndrome
(WAS) Wiskott-Aldrich syndrome protein (WASP)
Treg cell deﬁciency
T-cell oligoclonality Omenn syndrome (OS)
recombination activation genes
(RAG1,RAG2) Artemis IL-7R
zeta-associated protein, 70kD (ZAP-70,)
DNA ligase
Reduced NK cell
cytotoxicityskewed
Th1 phenotype
Comel-Netherton
syndrome (CNS)
Serin protease inhibitor Kazal type (SPINK)
lymphoepithelial Kazal type inhibitor
(LEKTI)
T-cell oligoclonality
DiGeorge syndrome
(DGS)—atypical complete
form
Microdeletion 22q11
Reduced Th17 cells
Treg cell
dysfunctionmultiple
cytokine signaling
defect
Hyperimmunoglobulin E
syndrome (HIES)
Signal transducer and activator of
transcription 3 (STAT3) dedicator of
cytokinesis 8 (DOCK8) tyrosine kinase 2
(Tyk2)
and downregulation of FcεRI and attenuation of the IgE-
dependent mast cell degranulation has been demonstrated
in context to lipoteichoic acid [63]. These data point to the
immunomodulatory function of mast cell TLR2 depending
on the stimulating bacterial product.
Interestingly, counterregulation of FcεRI, and TLR9
has been demonstrated on plasmacytoid dendritic cells.
The capacity of pDC to release type 1 interferon (IFN-α
and IFN-β) after TLR9 stimulation with speciﬁc ligands,
unmethylated CpG motifs is substantially decreased after
FcεRI aggregation and allergen challenge in vitro, indicating
a cross talk also among these receptors, TLR9 and FcεRI
[64]. Summarizing, costimulation of eﬀector cells on the
l e v e lo fT L R sa n dF c εRI may lead to diverse ultimate eﬀect,
either protective or promoting allergic response and eﬀective
or impaired antimicrobial immune responses under speciﬁc
conditions.
6. Effects of VitaminDon Immune Functions
There is an emerging evidence of the role of vitamin D not
only conﬁned to calcium and bone homeostasis, but also
to its pleiotropic and immunomodulatory eﬀect on both
innate and adaptive immune responses. The active form of
vitamin D, 1,25(OH)2D binds to the vitamin D receptor
(VDR),anuclearreceptorandligand-activatedtranscription
factor, expressed in many tissues and regulating cellular
diﬀerentiation and function of many cell types, including the
immune system. VDR expression is found, among others, in
macrophages, dendritic cells, NK cells, T cells, and B cells.
Upon activation, VDR elicits in these cells a potent anti-
proliferative, prodiﬀerentiative, and immunomodulatory
eﬀects on both transcription-dependent and transcription-
independent actions [65]. Vitamin D inhibits the function
of T lymphocytes both directly and via eﬀects on antigen-
presenting cells, particularly of Th1-associated cytokine
production and IL-17 production by Th17 lymph cells
involved in autoimmune and allergic processes, including
asthma. The eﬀect on Th2-mediated immune response is
more complex and the reports point to both its inhibition
and enhancement [66]. Vitamin D shows an inhibitory
eﬀect on dendritic cells by downregulating expression of
costimulatory molecules CD40 and CD80/86, decreasing
secretion of immunostimulatory IL-12. Concurrently, it
leads to increased production of anti-inﬂammatory IL-10 by
dendritic cells and CD4+CD25+ Treg cells.
In the lungs airway, epithelial cells have been found
to express high levels of 1alpha-hydroxylase, the vitamin
D-activating enzyme. Calcitriol has also been shown to
inhibit the synthesis and release of certain cytokines, such as
RANTES (regulated on activation, normal T-cell expressed
and secreted), PDGF (platelet-derived growth factor), and
matrix metalloproteinases from bronchial smooth muscle
cells, thereby leading to decreased inﬂammation and smooth
muscle cell proliferation [67]. Additionally, on animal
model, vitamin D receptors have been found in fetal type
II alveolar epithelial cells, which may according to recent
evidence play a role in the induction of regulatory T cells
[68]. In several clinical studies, association of vitamin D
with allergy and asthma has been investigated. In 2007,
two simultaneously published reports [69, 70]h a v ed e m o n -
strated higher risk of recurrent wheeze in children born
from women with low vitamin D intake during pregnancy.
Brehm et al. [71] showed a correlation between low levelsJournal of Allergy 7
of vitamin D and markers of asthma severity in children
including hospitalizations, the use of medications, and
airway hyperresponsiveness.
Therefore,vitaminDhasbeenfoundtoactasanimmun-
omodulator relevant to pathomechanisms of antimicrobial
response and allergy. In this context, vitamin D deﬁciency
might be considered as an immunodeﬁciency state predis-
posing to airway infections and to decreased tolerogenic
phenotype, with eﬀect on complex interactions between
genetic and environmental factors leading to development of
asthma.
7. Concluding Remarks
Multidirectional interactions and precise control of elements
of the immune response determine homeostasis between
eﬀector mechanisms and tolerance. Above-mentioned asso-
ciations between numerous elements of the immune system,
the innate as well as adaptive immune response, and
mechanisms predisposing to the development of allergy
suggest complex considering of the clinical problem of
recurrent airway inﬂammations in children. The above-
mentioned ﬁndings point to the pathogenetic relationship
between allergy and immune deﬁciencies which better than
mechanisms of atopy correlate with symptomatology of the
allergic diseases in children. These observations regarding
mainly young children and infants presenting transient
deﬁciencies of the immune response indicate a delayed
maturationofimmunologicalcomponentsasaphenomenon
of crucial importance. A dysregulation of the immune
response contributing to the defective antigen elimination
in the early childhood of the predisposed individual may be
considered as the critical risk factor preceding development
of allergy. The immune deﬁciencies and allergy have mutual
impact and are thus not precluding phenomena, but should
be considered as a speciﬁc overlapping syndrome.
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